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Cardiovascular disease is accompanied with enhanced oxidative stress (OS) in the vascular wall, heart, kidney, and brain. OS contributes to vascular injury 
by promoting inflammation, endothelial dysfunction and 
increased vascular tone, leading to altered vascular contractility, 
structural remodeling, and hypertension as well as other forms 
of cardiovascular disease. Hypertension is considered as a major 
risk of cardiovascular diseases worldwide. It has been evidenced 
that OS is increased in patients with salt-sensitive hypertension, 
essential hypertension, malignant hypertension, renovascular 
hypertension, preeclampsia as well as cyclosporine-induced 
hypertension (1). The mechanisms involved in generation of 
excess reactive oxygen species (ROS) and the mechanisms 
interfering with antioxidant defense in hypertension are not clear, 
too. Diminished antioxidant defense stems from deficiencies 
in glutathione peroxidase, catalase or superoxide dismutase. 
Attempts to target ROS are based on reducing ROS generation 
and increasing antioxidant bioavailability (2). Although 
excessive ROS are central pathway in induction and exacerbation 
of hypertension, however, there are controversies about the 
efficacy of antioxidant consumption in hypertension therapy (3). 
Some studies suggest that diets with high antioxidants content 
may reduce blood pressure and cardiovascular complications. 
Furthermore, it has been hypothesized that there might be a 
correlation between stress oxidative and arterial hypertension. 
In contrast, some randomized clinical and population studies 
have shown disappointing results. The variety in the results of 
different studies has been attributed to variety in trial design or 
dosing regimens. However, the potential pro-oxidant activity of 
antioxidants is a phenomenon which should not be ignored. It 
is generally recommended that general population, particularly 
the patients with OS induced complications should consume 
a balanced diet with emphasis on antioxidant-rich vegetables 
and fruits and whole grains (4). Antioxidants inhibit molecules’ 
oxidation which, in turn, produces free radicals capable of 
starting chain reactions. When the chain reaction starts in a 
cell, it could damage the cell or cause its death. By removing 
free radicals, antioxidants terminate these chain reactions 
and inhibit other oxidation reactions by being oxidized (5). 
Plants and animals have complex systems of multiple types of 
antioxidants, including glutathione, vitamins A, C,  E, as well 
as enzymes like superoxide dismutase, catalase, and several 
peroxidases (6,7). The diets rich in fruits and vegetables can 
reduce blood pressure in hypertensive and normotensive 
patients (8). In a study, increase in fruit and vegetable intake 
in the diet of hypertensive participants for 6 months led to 
increase in blood antioxidant capacity and decrease in systolic 
and diastolic blood pressure (9). Although these reports support 
the beneficial effect of dietary antioxidants on hypertension 
and cardiovascular risk, antioxidant supplementation has not 
been shown to be effective (10). A study reported that blood 
pressure did not improve after treatment with a mixture of 
vitamin C, vitamin E, and beta-carotene versus placebo after 
5 years in the participants who were thought to be at high 
risk of cardiovascular disease (11). Furthermore, a meta-
analysis revealed no improvement in cardiovascular-associated 
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Implication for health policy/practice/research/medical education:
Hypertension is considered as a major risk of cardiovascular diseases worldwide. It has been evidenced that 
oxidative stress is increased in patients with salt-sensitive hypertension, essential hypertension, malignant 
hypertension, renovascular hypertension, preeclampsia as well as cyclosporine-induced hypertension. 
Plants and animals have complex systems of multiple types of antioxidants, including glutathione, 
vitamins A, C,  and E, and enzymes like superoxide dismutase, catalase, and several peroxidases. The 
diets rich in fruits and vegetables can reduce blood pressure in hypertensive and normotensive patients.
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mortalities after antioxidant supplementation (12). According 
to the literature, we could conclude that, the diets high in 
antioxidants such as fruits and vegetables can reduce blood 
pressure and cardiovascular diseases, but this is not the case 
for diet supplementations (13). The possible reason is that, in 
the diet, there are various antioxidants working as a continuous 
chain, while supplementation is usually given using one or two 
substances. Therefore, the antioxidant chain is not completely 
available. It is also obvious that if an antioxidant, after scavenging 
free radicals, is not restored by the following antioxidant in 
the chain, it will gradually turn into a pro-oxidant. As a result, 
the ultimate effect of such supplementations would be no or a 
damaging effect (14,15).
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